Paiva Eliza Mara das Chagas, Moura Caroline de Castro, Nogueira Denismar Alves, Garcia Ana Cláudia Mesquita
Interdisciplinary Center for Studies in Palliative Care, Nursing School, Federal University of Alfenas, Alfenas 37130-001, Minas Gerais, Brazil.
Department of Medicine and Nursing, Federal University of Viçosa, Viçosa 36570-900, Minas Gerais, Brazil.
Healthcare (Basel). 2024 Jan 16;12(2):218. doi: 10.3390/healthcare12020218.
Auricular acupuncture (AA) has been used to manage chemotherapy-induced nausea and vomiting (CINV). However, the application of the technique varies widely among the clinical trials that test its effectiveness. The aim of the present study was to develop and clinically validate an AA protocol for the management of CINV in cancer patients. This study was carried out in two stages: (1) development of the AA protocol for the management of CINV and (2) clinical validation of the protocol. The content validity of the protocol was determined by a panel of specialists, with an agreement rate ranging from 85.7% to 100%. In the clinical validation, when administered to cancer patients, the protocol developed has been shown to reduce the incidence, frequency, severity, and length of nausea and vomiting following chemotherapy, as well as the severity of nausea and anticipatory nausea following chemotherapy. This protocol needs to be tested in future studies, including a pilot study with a sham group and a randomized clinical trial, in order to further evaluate its feasibility, acceptability, safety, and clinical usefulness for the management of CINV.
耳针疗法已被用于控制化疗引起的恶心和呕吐(CINV)。然而,在测试其有效性的临床试验中,该技术的应用差异很大。本研究的目的是开发并临床验证一种用于管理癌症患者CINV的耳针方案。本研究分两个阶段进行:(1)开发用于管理CINV的耳针方案;(2)对该方案进行临床验证。该方案的内容效度由一组专家确定,一致率在85.7%至100%之间。在临床验证中,当应用于癌症患者时,已开发的方案已显示可降低化疗后恶心和呕吐的发生率、频率、严重程度及持续时间,以及化疗后恶心和预期性恶心的严重程度。该方案需要在未来的研究中进行测试,包括有假治疗组的预试验和随机临床试验,以便进一步评估其在管理CINV方面的可行性、可接受性、安全性和临床实用性。